Seyed Hossein Shahcheraghi, Marzieh Lotfi, Mohammad Soukhtanloo, Majid Ghayour-Mobarhan, Hossein Zarei Jaliani, Hamid Reza Sadeghnia and Ahmad Ghorbani* Pages 1 - 9 ( 9 )
Background: Glioblastoma is one of the most aggressive tumors of central nervous system. Galbanic acid, a natural sesquiterpene coumarin, has shown favorable effects on cancerous cells in previous studies.
Objective: The aim of the present work was to evaluate the effects of galbanic acid on proliferation, migration, and apoptosis of the human malignant glioblastoma (U87) cells.
Methods: Anti-proliferative activity of the compound was determined by MTT assay. Cell cycle alterations and apoptosis were analyzed via flow cytometry. Action on cell migration was evaluated by scratch assay and gelatin zymography. Quantitative Real-Time PCR was used to determine the expression of genes involved in cell migration (matrix metalloproteinases, MMPs) and survival (the pathways of PI3K/Akt/mTOR and WNT/β-catenin). Alteration in the level of protein Akt was determined by Western blotting.
Results: Galbanic acid significantly decreased cell proliferation, inhibited cell cycle, and stimulated apoptosis of the glioblastoma cells. Also, it could decrease migration capability of glioblastoma cells, which was accompanied by an inhibition in the activity and expression of MMP2 and MMP9. While galbanic acid reduced the gene expression of Akt, mTOR, and PI3K and increased the PTEN expression, it had no significant effect on WNT, β-catenin, and APC genes. Also, the protein level of p-Akt decreased after treatment with galbanic acid. The effects of galbanic acid were observed at concentrations lower than those of temozolomide.
Conclusion: Galbanic acid decreased proliferation, cell cycle progression, and survival of glioblastoma cells through inhibiting PI3K/Akt/mTOR pathway. This compound also reduced migration capability of the cells by suppressing the activity and expression of MMPs.
Apoptosis, galbanic acid, glioblastoma, migration, matrix metalloproteinase, proliferation.
Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of medical sciences, Yazd, Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medicine Sciences, Mashhad, Department of Medical Biotechnology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad